Optimization of coronary sinus lead placement targeted to right-to-left delay in patients undergoing cardiac resynchronization therapy.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 23 06 2018
accepted: 18 10 2018
pubmed: 7 12 2018
medline: 22 9 2020
entrez: 4 12 2018
Statut: ppublish

Résumé

Anatomical placement of the coronary sinus (CS) lead in basal or mid-ventricular positions of the posterior and lateral walls is associated with a better clinical outcome of cardiac resynchronization therapy (CRT). We hypothesized that optimization of CS lead placement targeted the right-to-left electrical delay (RLD) predicts an additional clinical benefit. The CS lead was placed according to current standards in 90 patients (Conventional group) and at the site of the longest RLD in 121 patients (RLD group). Non-responders were defined as those who died or underwent hospitalization for heart failure or did not improve in their Clinical Composite Score within 6 months. There were 67 (32%) non-responders. Compared with Conventional group, the final CS pacing site was more frequently in the basal segments in the RLD group (40% vs. 23%, P = 0.007); moreover, the RLD ratio (%RLD) of the total QRS width was longer (77 ± 13 vs. 73 ± 15, P = 0.05) and biventricular QRS shortened more from the baseline (-31 ± 21 ms vs. -21 ± 26 ms, P = 0.004). Nevertheless, the rate of non-responders was similar in the RLD and Conventional groups (35% vs. 28%, P = 0.30), as was %RLD (76 ± 16 vs. 75 ± 13, P = 0.66). QRS width during right ventricular (RV) pacing was an independent predictors of adverse outcome, with a 2% increase in the risk of failure for each 1 ms increase in QRS (P = 0.006). Optimization of CS lead placement targeted to latest electrical activation does not provide additional clinical benefit to anatomical placement in basal or mid-ventricular positions of the posterior and lateral walls. QRS width during RV pacing was a strong predictor of CRT failure. http://www.clinicaltrials.gov. Unique identifier: NCT03204864.

Identifiants

pubmed: 30508076
pii: 5224770
doi: 10.1093/europace/euy275
doi:

Banques de données

ClinicalTrials.gov
['NCT03204864']

Types de publication

Clinical Study Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

502-510

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Auteurs

Daniele Oddone (D)

Arrhythmologic Center, Ospedali del Tigullio, Via Don Bobbio 24, Lavagna, Italy.

Diana Solari (D)

Arrhythmologic Center, Ospedali del Tigullio, Via Don Bobbio 24, Lavagna, Italy.

Giuseppe Arena (G)

Ospedale Apuane, Massa, Italy.

Roberto Mureddu (R)

Ospedale di Imperia, Imperia, Italy.

Renè Nangah (R)

Ospedale di Portogruaro, Portogruaro, Italy.

Davide Giorgi (D)

Ospedale S. Luca, Lucca, Italy.

Gaetano Senatore (G)

Ospedale Civile, Ciriè, Italy.

Nicola Bottoni (N)

Arcispedale S. Maria Nuova, Reggio Emilia, Italy.

Marzia Giaccardi (M)

Ospedale S. Maria Nuova, Firenze, Italy.

Mattia Laffi (M)

Ospedale Villa Scassi, Genova, Italy.

Massimo Giammaria (M)

Ospedale Maria Vittoria, Torino, Italy.

Nadir Sitta (N)

Ospedale di Conegliano, Conegliano, Italy.

Elena Marras (E)

Ospedale dell'Angelo, Mestre, Italy.

Eliana Cipolla (E)

Abbott, Roma, Italy.

Fabio Di Lorenzo (F)

Abbott, Roma, Italy.

Romina Carpi (R)

Abbott, Roma, Italy.

Michele Brignole (M)

Arrhythmologic Center, Ospedali del Tigullio, Via Don Bobbio 24, Lavagna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH